Pionyr Immunotherapeutics, Inc. announced it raised $38 Million in an initial filing from an offering of $62 Million

Dec 14, 2017•over 7 years ago

Amount Raised

$38 Million

San FranciscoHealthcare

Company Information

Company

PIONYR IMMUNOTHERAPEUTICS, INC.

Location

953 INDIANA STREET

San Francisco, California, United States

About

Pionyr develops drugs to perform exceptional fine-tuning of immune responses.

Medium Activity

Get personalized insights on buying likelihood

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech